Live Breaking News & Updates on Ameritas Investment Partners
Stay updated with breaking news from Ameritas investment partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enbridge Inc. (NYSE:ENB – Get Free Report) (TSE:ENB) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 22,640,000 shares, a drop of 72.1% from the May 15th total of 81,150,000 shares. Approximately 1.1% of the company’s stock are sold short. Based on an […] ....
The Vita Coco Company, Inc. (NASDAQ:COCO – Get Free Report) Director John Zupo sold 5,017 shares of Vita Coco stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $27.62, for a total transaction of $138,569.54. Following the sale, the director now directly owns 8,247 shares […] ....
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) was down 5.4% during trading on Tuesday . The stock traded as low as $34.87 and last traded at $34.91. Approximately 506,654 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 814,073 shares. The stock had previously closed at $36.92. […] ....
Central Garden & Pet (NASDAQ:CENTA – Get Free Report) was upgraded by stock analysts at Argus to a “strong-buy” rating in a report issued on Tuesday, Zacks.com reports. A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Central Garden & Pet from […] ....
CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $75.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 131.48% from the […] ....